TrialEuropean journal of medical research2010

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals.

M Vogel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.